A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.

沙利度胺治疗难治性子宫内膜癌患者的 II 期试验及其与血管生成生物标志物的相关性：妇科肿瘤组研究